LH vs. CAH

In the year-to-date period, LH achieves a 1.91% return, which is significantly lower than CAH's 19.02% return. Over the past 10 years, LH has outperformed CAH with an annualized return of 9.93%, while CAH has yielded a comparatively lower 6.80% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Laboratory Corporation of America Holdings (LH) and Cardinal Health, Inc. (CAH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current LH Sharpe Ratio is 0.24, which is lower than the CAH Sharpe Ratio of 1.00. The chart below compares the historical Sharpe Ratios of LH and CAH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

LH's dividend yield for the trailing twelve months is around 1.26%, less than CAH's 1.70% yield.

The maximum LH drawdown since its inception was -96.05%, which is greater than CAH's maximum drawdown of -61.58%. Use the drawdown chart below to compare losses from any high point for LH and CAH. For additional features, visit the drawdowns tool.

The current volatility for Laboratory Corporation of America Holdings (LH) is 4.79%, while Cardinal Health, Inc. (CAH) has a volatility of 5.40%. This indicates that LH experiences smaller price fluctuations and is considered to be less risky than CAH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Laboratory Corporation of America Holdings and Cardinal Health, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.